These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23449698)

  • 1. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution.
    Lamb EJ; Levey AS; Stevens PE
    Clin Chem; 2013 Mar; 59(3):462-5. PubMed ID: 23449698
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
    Inker LA; Astor BC; Fox CH; Isakova T; Lash JP; Peralta CA; Kurella Tamura M; Feldman HI
    Am J Kidney Dis; 2014 May; 63(5):713-35. PubMed ID: 24647050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Albuminuria: when urine predicts kidney and cardiovascular disease.
    Stephen R; Jolly SE; Nally JV; Navaneethan SD
    Cleve Clin J Med; 2014 Jan; 81(1):41-50. PubMed ID: 24391106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Should the definition of CKD be changed to include age-adapted GFR criteria?": Con: the evaluation and management of CKD, not the definition, should be age-adapted.
    Levey AS; Inker LA; Coresh J
    Kidney Int; 2020 Jan; 97(1):37-40. PubMed ID: 31901355
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline.
    Stevens PE; Levin A;
    Ann Intern Med; 2013 Jun; 158(11):825-30. PubMed ID: 23732715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.
    Levey AS; de Jong PE; Coresh J; El Nahas M; Astor BC; Matsushita K; Gansevoort RT; Kasiske BL; Eckardt KU
    Kidney Int; 2011 Jul; 80(1):17-28. PubMed ID: 21150873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Water renal management is altered more frequently than albuminuria in children in the G1 stage of the 2012 KDIGO Guideline.
    García-Nieto VM; Fortich F; Luis-Yanes MI; Tripodi C; Arango-Sancho P
    Nefrologia; 2015; 35(1):66-71. PubMed ID: 25611835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying severity of chronic kidney disease as a risk factor for acute kidney injury.
    Cho K; Hsu CY
    J Am Soc Nephrol; 2010 Oct; 21(10):1602-4. PubMed ID: 20829406
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chronic Kidney Disease - Update 2018].
    Ketteler M; Wanner C
    Dtsch Med Wochenschr; 2018 Feb; 143(3):169-173. PubMed ID: 29409087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of chronic kidney disease after preeclampsia.
    Lopes van Balen VA; Spaan JJ; Cornelis T; Spaanderman MEA
    J Nephrol; 2017 Jun; 30(3):403-409. PubMed ID: 27491315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR; Evans M; Yule C; Bohn L; Young A; Lewis M; Graboski E; Gerdy B; Ehmann W; Brady J; Lawrence L; Antunes N; Green J; Snyder S; Kirchner HL; Grams M; Perkins R
    BMC Nephrol; 2016 Nov; 17(1):168. PubMed ID: 27825313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposal for improving the KDIGO renal disease risk table.
    Robles NR; Macias JF; Alvarez-Gregori J
    Int Urol Nephrol; 2012 Oct; 44(5):1431-3. PubMed ID: 22735928
    [No Abstract]   [Full Text] [Related]  

  • 15. The elderly patient with low eGFR: beyond the numbers.
    Azar M
    R I Med J (2013); 2014 Dec; 97(12):19-23. PubMed ID: 25463622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Development of evaluation of kidney function and classification of chronic kidney disease (CKD)--including CKD clinical practice guide 2012].
    Horio M
    Rinsho Byori; 2013 Jul; 61(7):616-21. PubMed ID: 24205704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for using albuminuria in staging chronic kidney disease.
    Gansevoort RT; de Jong PE
    J Am Soc Nephrol; 2009 Mar; 20(3):465-8. PubMed ID: 19255126
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic Kidney Disease: Detection and Evaluation.
    Gaitonde DY; Cook DL; Rivera IM
    Am Fam Physician; 2017 Dec; 96(12):776-783. PubMed ID: 29431364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the feasibility of the KDIGO CKD referral recommendations.
    Singh K; Waikar SS; Samal L
    BMC Nephrol; 2017 Jul; 18(1):223. PubMed ID: 28687072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between urinary sodium, creatinine, albumin, and long-term survival in chronic kidney disease.
    McQuarrie EP; Traynor JP; Taylor AH; Freel EM; Fox JG; Jardine AG; Mark PB
    Hypertension; 2014 Jul; 64(1):111-7. PubMed ID: 24732890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.